Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen

Cancer Research

Volumn 56, Issue 17, 1996, Pages 3954-3960

  Hyder, Salman M ^a   Stancel, George M ^a   Chiappetta, Constance ^a   Murthy, Lata ^a,b   Boettger Tong, Holly L ^a   Makela, Sari ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; DACTINOMYCIN; ESTRADIOL; MESSENGER RNA; NAFOXIDINE; PUROMYCIN; TAMOXIFEN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE REGENERATION; TRANSCRIPTION REGULATION; UTERUS TUMOR;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; LYMPHOKINES; RATS; RATS, SPRAGUE-DAWLEY; RNA; RNA SPLICING; RNA, MESSENGER; TAMOXIFEN; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029794465     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ferrara, N., Houck, K., Jakeman, L., and Leung, D. W. Molecular and biological properties of the vascular endothelial growth factor Endocr. Rev., 13: 18-32, 1992
2. Dvorak, H. F , Brown, L. F , Detmar, M., and Dvorak, A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J Pathol., 146: 1029-1039, 1995
3. Kolch, W., Martiny-Baron, G., Kieser, A., and Marmé, D Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res. Treat., 36: 139-155, 1995.
4. Bacic, M , Edwards, N. A., and Merrill, M. J. Differential expression of vascular endothelial growth factor (vascular permeability factor) forms m rat tissues Growth Factors, 12: 11-15, 1995.
5. Cullinan-Bove, K., and Koos, R D Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus, rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology, 133: 829-837, 1993
6. Shweiki, D , Itin, A., Neufeld, G., Gitay-Goren, H., and Keshet, E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin. Invest., 91: 2235-2243, 1993.
7. Chlebowski, R. T., Butler, J., Nelson, A., and Lillington, L. Breast cancer chemoprevention, tamoxifen: current issues and future prospective Cancer (Phila.), 72 (Suppl.): 1032-1037, 1993.
8. Van den Koedijk, C. D. M. A., Blankenstein, M A., and Thijssen, J. H. H. Speculation on the mechanism of action of triphenylethylene antioestrogens. Biochem. Pharmacol. 47: 1927-1937, 1994.
9. Friedl, A., and Jordan, V. C. What do we know and what don't we know about tamoxifen in the human uterus? Breast Cancer Res. Treat, 31: 27-39, 1994.
10. Jordan, V C. Molecular mechanisms of antiestrogen action in breast cancer. Breast Cancer Res. Treat., 31: 41-52, 1994
11. Fisher, B., Costantino, J P., Redmond, C. K., Fisher, E. R., Wickerham, D. L., Cronin, W. M., and NSABP contributors Endometnal cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J. Natl. Cancer Inst., 86: 527-537, 1994.
12. Chirgwin, J M , Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acids from sources enriched in ribonucleases Biochemistry, 18: 5294-5299, 1979
13. Loose-Mitchell, D. S., Chiappetta, C., and Stancel, G. M. Estrogen regulation of c-fos messenger ribonucleic acid. Mol. Endocrinol , 2: 946-951, 1988.
14. Hsu, C. J , Komm, B. S., Lyttle, C. R., and Frankel, F. R Cloning of esirogen regulated messenger ribonucleic acids from rat uterus. Endocrinology, 122: 631-639, 1988
15. Hyder, S. M., Hu, C., Needleman, D. S., Sonoda, Y., Wang, X-Y., and Baker, V. V. Improved accuracy in automated DNA sequencing. BioTechniques, 17: 478-482, 1994.
16. Simmons, D. M , Arnza, J. L., and Swanson, L. W. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radiolabeled single-stranded RNA probes. J. Histotechnol., 12: 169-181, 1989.
17. Pierce, E. A., Avery, R. L , Foley, E. D., Aiello, L. P., and Smith, L. E H. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad Sci. USA, 92: 905-909, 1995.
18. Takahashi, A , Sasaki, H , Kim, S J , Tobisu, K-I, Kakizoe, T., Tsukamato, T., Kumamato, Y., Sugimura, T., and Terada, M. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis Cancer Res., 54: 4233-4237, 1994.
19. Plate, K. H., Brier, G , Weich, H. A , and Risau, W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature (Lond), 359: 845-848, 1992.
20. Weindel, K., Marine, D., and Weich, H. A. AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. Biochem. Biophys Res. Commun., 183: 1167-1174, 1992
21. Kirkland, J. L., Murthy, L., and Stancel, G. M. Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus. Mol. Pharmacol., 43: 709-714, 1993.
22. Charnock-Jones, D. S., Sharkey, A. M., Rajput-Williams, J., Burch, D., Schofield, J P., Fountain, S A., Boocock, C. A., and Smith, S. K Identification and localization of alternatively spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines Biol Reprod., 48, 1120-1128, 1993.
23. Nephew, K. P., Peters, G A , and Khan, S A. Cellular localization of estradiol-induced c-fos messenger ribonucleic acid in the rat uterus: c-fos expression and uterine cell proliferation do not correlate strictly. Endocrinology, 136: 3007-3015, 1995.
24. Chiappetta, C , Kirkland, J. L , Loose-Mitchell, D. S , Murthy, L , and Stancel, G M. Estrogen regulates expression of the jun family of protooncogenes in the uterus J. Steroid Biochem. Mol. Biol, 41: 113-123, 1992.
25. Webb, D. K , Moulton, B. C., and Khan, S. A. Estrogen induces expression of c-jun and jun-B protooncogenes in specific rat uterine cells. Biochem. Biophys. Res. Commun,. 168: 721-726, 1990.
26. Cicatiello, L., Ambrosino, C., Coletta, B , Scalona, M., Sica, V., Bresciani, F., and Weisz, A Transcriptional activation of jun and actin genes by estrogen during mitogenic stimulation of rat uterine cells. J. Steroid Biochem. Mol. Biol. 41: 523-528, 1992
27. Weisz, A., and Bresciani, F. Estrogen induces expression of c-fos and c-myc in rat uterus Mol. Endocrinol., 2: 816-824, 1988.
28. Cicatiello, L., Sica, V , Bresciani, F., and Weisz, A. Identification of a specific pattern of "immediate-early" gene activation induced by estrogen during mitogenic stimulation of rat uterine cells. Receptor, 3: 17-30, 1993.
29. Hyder, S. M., Stancel, G M., and Loose-Mitcheli, D S. Steroid hormone-induced expression of oncogene encoded nuclear proteins. Crit. Rev. Eukaryotic Gene Expr., 4: 55-116, 1994.
30. Nephew, K. P., Polek, T C., Akcali, K C., and Khan, S. A. The antiestrogen tamoxifen induces c-fos and jun-B, but not c-jun or jun-D protooncogenes in the rat uterus. Endocrinology, 133: 419-422, 1993.
31. Jordan, V. C., Dix, C. J., Rowsby, L., and Prestwich, G. Studies on the mechanism of action of the nonsteroidal antiestrogen tamoxifen (I C.I. 46,474) in the rat. Mol Cell. Endocrinol., 7: 177-192, 1977
32. Yamashita, S., Newbold, R. R., McLachtan, J., and Korach, K S Developmental pattern of estrogen receptor expression in female mouse genital tract. Endocrinology, 725: 2888-2896, 1989.
33. Li, X. F., Gregory, I., and Ahmed, A. Immunolocaltsation of vascular endothelial growth factor in human endometrium Growth Factors, 11: 277-282, 1994.
34. Kirkland, J. L., LaPointe, L., Justin, E., and Stancel, G. M. Effect of estrogen on mitosis in individual cell types of the immature rat uterus. Biol. Reprod., 21: 269-272, 1979
35. Uziley, B., Lewin, A , Brufman, G , Dorembus, D., and Mor-Yosef, S. The effect of tamoxifen on the endometrium. Breast Cancer Res. Treat., 26: 101-105, 1993.
36. Seoud, M. A., Johnson, J , and Weed, J. C., Jr. Gynecological tumors in tamoxifen treated women with breast cancer. Obstet. Gynecol., 82: 165-169, 1993.
37. Paganmi-Hill, A. The risks and benefits of estrogen replacement therapy: Leisure World. Int. J. Fertil. Menopause Studies, 1: 54-62, 1995.
38. Robinson, D C., Bloss, J. D., and Schiano, M. A. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients. Gynecol Oncol., 59: 186-190, 1995
39. Plowman, P. N Tamoxifen as adjuvant therapy in breast cancer. Current status Drugs, 46: 819-833, 1993.
40. Nease, R F., Jr., and Ross, J. M. The decision to enter a randomized trial of tamoxifen for the prevention of breast cancer in healthy women - an analysis of the trade off Am. J. Med, 99: 180-189, 1995.